CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Stannous fluoride toothpaste +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03965039
NCT03965039N/ACompleted

A Randomized Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity

Procter and Gamble·interventional·Posted May 28, 2019·Updated Oct 30, 2020

In Brief

A clinical study evaluating Dipotassium oxalate toothpaste, Stannous fluoride toothpaste, and 2 other interventions for Dentin Hypersensitivity. Completed, enrolled 120 participants across 1 site.

Detailed Summary

The objective of this study is to evaluate the efficacy (changes in dentinal hypersensitivity) and safety (oral soft tissue evaluation) after use of one of four dentifrices in subjects with pre-existing hypersensitivity over an 11-week period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 28, 2019
Enrollment StartJul 8, 2019
Primary CompletionOct 3, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.1 years ago

Interventions

Dipotassium oxalate toothpastedevice

Experimental dipotassium oxalate (3%) toothpaste

Stannous fluoride toothpastedrug

Marketed stannous fluoride (0.454%) toothpaste

Potassium nitrate toothpastedrug

Marketed potassium nitrate (5%) toothpaste

Sodium monofluorophosphate toothpastedrug

Marketed sodium monofluorophosphate (0.76%) toothpaste